Meet Inspiring Speakers and Experts at our 3000+ Global Conference Series LLC LTD Events with over 1000+ Conferences, 1000+ Symposiums
and 1000+ Workshops on Medical, Pharma, Engineering, Science, Technology and Business.
Explore and learn more about Conference Series LLC LTD : World’s leading Event Organizer
As per available reports about 13 relevant journals, 2648 Conferences, 35 workshops are presently dedicated exclusively to breathing disorder and about 14 articles are being published on breathing disorder.
OMICS International Organizes 1000+ Global Events Every Year across USA, Europe & Asia with support from 1000 more scientific societies and Publishes 700+ Open access journals which contains over 100000 eminent personalities, reputed scientists as editorial board and organizing committee members. The conference series website will provide you list and details about the conference organize worldwide.
Scope and Importance:
A neoplasm can be benign, potentially malignant (pre-cancer), or malignant (cancer)
Benign neoplasm - includes uterine fibroids and melanocytic nevi (skin moles). They are circumscribed and localized and do not transform into cancer.
Potentially malignant neoplasm’s include carcinoma in situ. They do not invade and destroy but, given enough time, will transform into a cancer.
Malignant neoplasm’s are commonly called cancer. They invade and destroy the surrounding tissue, may form metastases and eventually kill the host.
Secondary neoplasm erefers to any of a class of cancerous tumor that is either a metastatic offshoot of a primary tumor, or an apparently unrelated tumor that increases in frequency following certain cancer treatments such as chemotherapy or radiotherapy.
This symposium should be of interest to physicians practicing all subspecialties of oncology, as well as professionals involved in human genetics, genetic counseling, and molecularly-based clinical trials design and implementation. Around 30 – 35 workshops and symposium will be held in 2015 in all around the world these include “Keystone symposium”.
Some of the tumor associations are Canadian Cancer Society, Lymphoma association, the European association for cancer research, Cancer research UK, cancer research institution.
The global oncology drugs market is expected to reach at $111.9 billion by 2020. Patent expiration of key cancer drugs such as Herceptin, Erbitux, Rituxan and Avastin, is expected to boost the growth of cancer biosimilars market by 2020. Going further, the biological therapies are expected to dominate the market by 2020, due to their high efficacy, target specific action and less toxicity. Blood cancer drugs market was the largest revenue generating segment in 2013 owing to the high cost of drugs (immunotherapies) used for the treatment of blood cancer.
This page will be updated regularly.
This page was last updated on August 4, 2020